PF-1355, a Mechanism-Based Myeloperoxidase Inhibitor, Prevents Immune Complex Vasculitis and Anti–Glomerular Basement Membrane Glomerulonephritis
Year: 2015
Type: article
Authors: Wei Zheng, Roscoe Warner, Roger Ruggeri, Chunyan Su, Christian Cortes, Athanasia Skoura, Jessica Ward, Kay Ahn, Amit Kalgutkar, Dexue Sun, Tristan S. Maurer, Paul D. Bonin, Carlin Okerberg, Walter Bobrowski, Thomas Kawabe, Yanwei Zhang, Timothy Coskran, Sammy Bell, Bhupesh Kapoor, Kent Johnson, Leonard Buckbinder
Institutions: Pfizer (United States), University of Michigan
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: myeloperoxidase inhibition, immune complex vasculitis, Goodpasture's syndrome, small vessel vasculitis, 2-thiouracil, hypochlorous acid, neutrophil recruitment, oxidative stress, pharmacokinetic-pharmacodynamic modeling, peritonitis, albuminuria, chronic renal dysfunction, pulmonary vasculitis
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W2082821079
